Dale Q Rice Investment Management Ltd Acquires Shares of 5,899 iShares Biotechnology ETF (NASDAQ:IBB)

Dale Q Rice Investment Management Ltd bought a new stake in iShares Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 5,899 shares of the financial services provider’s stock, valued at approximately $780,000.

A number of other institutional investors have also recently made changes to their positions in IBB. BNP Paribas Financial Markets lifted its holdings in iShares Biotechnology ETF by 29.3% during the third quarter. BNP Paribas Financial Markets now owns 2,380,229 shares of the financial services provider’s stock valued at $346,561,000 after purchasing an additional 538,899 shares during the last quarter. Commerce Bank raised its position in shares of iShares Biotechnology ETF by 1.8% in the third quarter. Commerce Bank now owns 743,366 shares of the financial services provider’s stock valued at $108,234,000 after purchasing an additional 12,921 shares during the period. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of iShares Biotechnology ETF by 32.9% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 663,000 shares of the financial services provider’s stock valued at $96,533,000 after buying an additional 164,000 shares in the last quarter. Main Management ETF Advisors LLC boosted its holdings in iShares Biotechnology ETF by 2.5% in the 3rd quarter. Main Management ETF Advisors LLC now owns 593,370 shares of the financial services provider’s stock worth $86,395,000 after buying an additional 14,535 shares during the period. Finally, Aprio Wealth Management LLC purchased a new position in iShares Biotechnology ETF in the 4th quarter valued at approximately $18,476,000. Hedge funds and other institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

NASDAQ:IBB opened at $134.02 on Tuesday. iShares Biotechnology ETF has a 1 year low of $123.60 and a 1 year high of $150.57. The stock’s fifty day moving average price is $137.95 and its two-hundred day moving average price is $141.99.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.